The Ivermectin mess in Indonesia. How a state destroys a winning situation
What happened in Indonesia on the use and production of ivermectin is a worldwide scandal, which shows the ability of governments to act against the interests of their citizens, even when they have organized themselves autonomously.
A skilled entrepreneur and philanthropist, Mr. Haryoseno, ran a company in Jakarta called Harsen Laboratories. By last summer, the canny businessman saw the potential of ivermectin and invested to conquer the market in Indonesia with Ivermax 12.
From sourcing raw materials and other inputs to optimizing a supply chain, Mr. Haryoseno has designed an optimized ivermectin production and distribution apparatus that supplies people across the country, including influential people. He was even commissioned to supply ivermectin to the Indonesian Air Force.
Harsen Laboratories' ivermectin-based product Ivermax 12 was available in local pharmacies at a price of $ 18 for a pack of 10 tablets, and sales have continued to soar. Of course, no correlation can be shown to a stabilized pandemic, but cases remained relatively small, with the exception of a small wave from December to January, which rapidly subsided, but no major wave occurred until June of this one. year.
So what happened?
Simple, the Indonesian state interfered in Mr. Haryoseno's business by usurping the ivermectin license. After all, according to them, he was breaking the law by distributing the drug for more than just a parasite-borne disease. In June of this year, BPOM, the drug regulatory agency, announced that ivermectin would be used for COVID-19 and that the license would be redirected to state-owned PT Indofarma. BPOM's ivermectin statement can be reviewed here .
Now under the firm control of the state-owned enterprise called PT Indofarma, BPOM has stepped up its real program of using ivermectin only for its own large mass trial program, not actually distributing it as medicine. Too bad that he was not even able to guarantee supplies for the test, so much so that he had to contact Harsen in order to obtain the supplies of raw materials necessary for controlled production. It may be a coincidence but since the production of Ivermectin went into the hands of the state the cases have exploded.
Yet another case in which a useful drug was forcibly sidelined with the direct intervention of the state.
Thanks to our Telegram channel you can stay updated on the publication of new articles of Economic Scenarios.
The article The mess of Ivermectin in Indonesia. How a state destroys a winning situation comes from ScenariEconomici.it .
This is a machine translation of a post published on Scenari Economici at the URL https://scenarieconomici.it/il-pasticciaccio-dellivermectin-in-indonesia-come-uno-stato-distrugge-una-situazione-vincente/ on Fri, 16 Jul 2021 08:41:16 +0000.